Summary
The FDA has granted Orphan Drug status to a synthetic cannabis flavonoid, derived from a rare strain of Jamaican ganja, that can help treat pancreatic cancer.
Article Preview
The federal government has granted approval to a new series of clinical trials that will evaluate whether a cannabis flavonoid derived from a rare Jamaican strain of weed can help fight pancreatic cancer.
Most research into the medical properties of cannabis have focused on individual, well-known cannabinoids like THC and CBD. But last summer, a study published in the Frontiers in Oncology journal reported that cannflavin B...
Read the full article @ Merry Jane